Commodore Capital LP - 10 Nov 2025 SCHEDULE 13G Report for Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (AMLX)

Filing Manager
Commodore Capital LP
Reporting Manager
Commodore Capital LP
Security
Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
AMLX
Shares outstanding
111M shares
Disclosed Ownership
5.65M shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
17 Nov 2025, 17:39:36 UTC
Date of event
10 Nov 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Commodore Capital LP 5.1% 5.65M 0 5.65M Michael Kramarz Managing Partner
Commodore Capital Master LP 5.1% 5.65M 0 5.65M Michael Kramarz Authorized Signatory
Robert Egen Atkinson 5.1% 5.65M 0 5.65M Robert Egen Atkinson Authorized Signatory
Michael Kramarz 5.1% 5.65M 0 5.65M Michael Kramarz Authorized Signatory